SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000891293-15-000028
Filing Date
2015-07-29
Accepted
2015-07-29 17:17:37
Documents
2
Period of Report
2015-07-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1525
2 POWER OF ATTORNEY poa.txt EX-24 3301
  Complete submission text file 0000891293-15-000028.txt   6267
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
SEELEY BRUCE J. (Reporting) CIK: 0001474462 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12465 | Film No.: 151013623